EVOEvotec SE

Nasdaq evotec.com


$ 5.29 $ -0.10 (-1.86 %)    

Friday, 03-May-2024 15:45:32 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 5.27
$ 5.28
$ 0.00 x 0
$ 0.00 x 0
$ 5.28 - $ 5.29
$ 4.87 - $ 13.49
172,799
na
932.54M
$ 0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bayer-and-evotec-collaborate-to-advance-precision-cardiology-financial-terms-undisclosed

Bayer and the German-based life science company, Evotec, announced today that they have updated the focus of their strategic co...

 hc-wainwright--co-maintains-buy-on-evotec-lowers-price-target-to-11

HC Wainwright & Co. analyst Douglas Tsao maintains Evotec (NASDAQ:EVO) with a Buy and lowers the price target from $14 t...

 life-science-focused-evotec-shares-plunge-to-6-year-lows-on-gloomy-annual-forecast

Evotec undergoes a strategic shift for sustainable growth in 2024. Priority reset to optimize operations; expect double-digit r...

 evotec-variant-bio-announce-collaboration-agreement-to-identify-treatment-for-diseases-caused-by-fibrosis

Under the terms of the risk-sharing partnership, Evotec will receive undisclosed research funding and may receive pre-clinical ...

 evotec-and-claris-ventures-streamline-access-to-accelerate-programmes-from-clariss-portfolio-companies-into-the-clinic

Claris's portfolio companies receive easy access to Evotec's full range of pre-clinical and clinical development and ma...

 new-jersey-division-of-gaming-enforcement-has-closed-its-investigation-of-evolution-ab-with-no-further-action

 Evolution AB has been informed by the New Jersey Division of Gaming Enforcement (NJDGE) that it has conducted an investigation...

 evotec-subsidiary-just---evotec-biologics-expands-development-and-manufacturing-agreement-with-abl-for-broadly-neutralising-antibodies-against-hiv-financial-terms-undisclosed

Evotec SE ((Frankfurt Stock Exchange: EVT, MDAX/TecDAX, OTC:EVOTF, NASDAQ:EVO) today announced that its Seattle-based subsidiar...

 whats-going-on-with-life-science-company-evotec-stock-today

Evotec SE (NASDAQ: EVO) joined forces with the Crohn's & Colitis Foundation to advance drug discovery and identify nove...

 evotec-and-crohns--colitis-foundation-enter-agreement-to-advance-drug-discovery-for-novel-ibd-therapies---eqs-news

https://www.eqs-news.com/news/corporate/evotec-and-crohns-colitis-foundation-enter-agreement-to-advance-drug-discovery-for-nove...

Core News & Articles

Evotec and Bristol Myers Squibb entered their strategic neuroscience collaboration in December 2016 to identify disease-modifyi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION